Zafrens

About:

Zafrens offers a throughput platform for cell characterization, correlating molecular profiles to phenotype for accelerated drug discovery.

Website: https://www.zafrens.com/

Top Investors: Global Brain Corporation, Liquid 2 Ventures, BlueYard Capital, KOFA Healthcare, Alix Ventures

Description:

Zafrens is a drug discovery company that develops life sciences products that allow full characterization of diverse cell populations. The company's platform specializes in generating insights at the interface of biology, chemistry, and engineering. The company was founded in 2021 and is headquartered in San Diego, California, United States.